These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29972084)

  • 21. Comparative effectiveness research in follicular lymphoma: current and future perspectives and challenges.
    Wudhikarn K; Link BK
    J Comp Eff Res; 2014 Jan; 3(1):95-107. PubMed ID: 24345259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current controversies in follicular lymphoma.
    Aurora V; Winter JN
    Blood Rev; 2006 Jul; 20(4):179-200. PubMed ID: 16410034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study.
    Rajguru S; Kristinsdottir T; Eickhoff J; Peterson C; Meyer CM; Traynor AM; Kahl BS
    Clin Adv Hematol Oncol; 2014 Aug; 12(8):509-15. PubMed ID: 25356575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How we manage follicular lymphoma.
    Hiddemann W; Cheson BD
    Leukemia; 2014 Jul; 28(7):1388-95. PubMed ID: 24577532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renewed interest for low-dose radiation therapy in follicular lymphomas: From biology to clinical applications.
    Ciammella P; Luminari S; Arcaini L; Filippi AR
    Hematol Oncol; 2018 Dec; 36(5):723-732. PubMed ID: 30146794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unmet needs in the first-line treatment of follicular lymphoma.
    Casulo C; Nastoupil L; Fowler NH; Friedberg JW; Flowers CR
    Ann Oncol; 2017 Sep; 28(9):2094-2106. PubMed ID: 28430865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysis.
    Prica A; Chan K; Cheung M
    Cancer; 2015 Aug; 121(15):2637-45. PubMed ID: 25877511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
    Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
    Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of genetic targets for guiding clinical management of follicular lymphoma.
    Alonso-Alonso R; Rodriguez M; Morillo D; Cordoba R; Piris MA
    Expert Rev Hematol; 2020 Dec; 13(12):1361-1372. PubMed ID: 33176509
    [No Abstract]   [Full Text] [Related]  

  • 30. Current management of follicular lymphomas.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Unterhalt M
    Br J Haematol; 2007 Jan; 136(2):191-202. PubMed ID: 17073892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment strategies in advanced stage follicular lymphoma.
    van Oers MH; Kersten MJ
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):187-201. PubMed ID: 21658618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract.
    Iwamuro M; Tanaka T; Ennishi D; Otsuka M
    Expert Rev Gastroenterol Hepatol; 2024 Jul; 18(7):367-375. PubMed ID: 38997226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follicular lymphoma: the case for timely intervention.
    McLaughlin P
    Expert Rev Hematol; 2009 Jun; 2(3):277-84. PubMed ID: 21082969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a role for "watch and wait" in follicular lymphoma in the rituximab era?
    Kahl B
    Hematology Am Soc Hematol Educ Program; 2012; 2012():433-8. PubMed ID: 23233615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
    Cohen Y; Solal-Céligny P; Polliack A
    Haematologica; 2003 Jul; 88(7):811-23. PubMed ID: 12857561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel acquisitions on biology and management of transformed follicular lymphoma.
    Minoia C; Zucca E; Conconi A
    Hematol Oncol; 2018 Oct; 36(4):617-623. PubMed ID: 29602222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cost-effectiveness analysis of maintenance therapy with rituximab in patients with follicular lymphoma responding to induction therapy at the first line].
    Castro Gómez AJ; López-Guillermo A; Rueda Domínguez A; Salar A; Varela Moreno C; Rubio-Terrés C
    Rev Esp Salud Publica; 2012; 86(2):163-76. PubMed ID: 22991059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management options for follicular lymphoma: observe; R-CHOP; B-R; others?
    McLaughlin P
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S91-5. PubMed ID: 22035757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Therapy Approaches to Follicular Lymphoma.
    Northend M; Townsend W
    Drugs; 2021 Mar; 81(4):453-469. PubMed ID: 33616890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.
    Barzenje DA; Cvancarova Småstuen M; Liestøl K; Fosså A; Delabie J; Kolstad A; Holte H
    PLoS One; 2015; 10(7):e0131158. PubMed ID: 26147646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.